常见心血管疾病患者流行性感冒疫苗接种专家意见
Expert opinions on influenza vaccination for patients with common cardiovascular diseases
全国心血管疾病管理能力评估与提升工程(CDQI)心力衰竭中心专家组 杜昕 1马长生2
作者信息
- 1. 首都医科大学附属北京安贞医院心内科北京心联乔治心脏健康研究所,北京100029
- 2. 首都医科大学附属北京安贞医院心内科,北京 100029
- 折叠
摘要
流行性感冒(流感)病毒属于正黏病毒科的单股负链RNA病毒,具有与普通感冒不同的流行特征.流感病毒感染可通过多种途径引起心脏损伤.心血管疾病患者感染流感病毒后将面临更高的风险.流感疫苗接种对心血管疾病患者具有保护作用,可降低全因死亡、心血管相关死亡等不良结局的发生率.现阶段,我国心血管疾病患者的流感疫苗接种率较低.为此,本文整理了国内外临床研究进展及相关指南,参考心血管患者接种流感疫苗的有效性和安全性,结合各领域专家的经验,提出了心血管疾病患者流感疫苗接种的专家意见,旨在提高心血管疾病患者流感预防意识,改善心血管疾病的结局.
Abstract
The influenza virus is classified as a single-stranded negative-sense RNA virus in Orthomyxoviridae family,with epidemiological properties distinct from common cold.Previous studies have found that influenza infection can cause cardiac damage through various pathways,and patients with cardiovascular diseases are at relatively higher risk of adverse disease outcomes.Influenza vaccination has been proven to provide protective effect on patients with cardiovascular diseases.Currently,there is insufficient emphasis placed by cardiologists and cardiovascular disease patients on the prevention of influenza infection,leading to a low influenza vaccination rate in China.Therefore,based on the current clinical research progress and relevant guidelines,combined with the safety,feasibility and health economic benefits of influenza vaccinating in patients with cardiovascular diseases,as well as clinical experience from experts,this article proposes expert opinions on influenza vaccination in common cardiovascular diseases aiming to raise awareness of influenza prevention and benefiting patients.
关键词
心血管疾病/预防/流行性感冒/疫苗接种Key words
Cardiovascular diseases/Prevention/Influenza/Vaccination引用本文复制引用
出版年
2025
NETL
NSTL
万方数据